Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nasser Al-Ahmed

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Peanut allergy: an overviewNasser Al-Ahmed, Shirina Alsowaidi, Peter Vadas
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 8, 2018
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for AsthmaMona Al-Ahmad, Nermina Arifhodzic, Jasmina Nurkic, et al.
The Journal of Dermatological Treatment|January 6, 2025
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countriesAmani Alfalasi, Ahmed Ameen, Atlal Al Lafi, et al.
Allergy|September 13, 2025
The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D StudyKanokvalai Kulthanan, Jonathan A Bernstein, Michael Rudenko, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|June 8, 2010
Peanut allergy: an overviewNasser Al-Ahmed, Shirina Alsowaidi, Peter Vadas
Medical Principles and Practice : International Journal of the Kuwait University, Health Science Centre|February 8, 2018
"Real-life" Efficacy and Safety Aspects of 4-Year Omalizumab Treatment for AsthmaMona Al-Ahmad, Nermina Arifhodzic, Jasmina Nurkic, et al.
The Journal of Dermatological Treatment|January 6, 2025
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countriesAmani Alfalasi, Ahmed Ameen, Atlal Al Lafi, et al.
Allergy|September 13, 2025
The Prevalence of Symptomatic Dermographism: Results of the International UCARE PREVALENCE-D StudyKanokvalai Kulthanan, Jonathan A Bernstein, Michael Rudenko, et al.
Pageof 1